CONNECT WITH US
HealthTech

HealthTech

New treatment may cure common hormonal cause of high blood pressure

Medical Xpress logo

Published on

Add as a preferred source on Google
New treatment may cure common hormonal cause of high blood pressure

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

A study led by Queen Mary University of London has found that a new treatment could offer a lasting cure for some people with a common hormonal cause of high blood pressure, even after they stop taking medication.

The treatment, known as extended aldosterone synthase inhibition (EASI), involves taking a new class of drugs for 6–12 months to target excess production of the hormone aldosterone, a common cause of high blood pressure. Unlike conventional treatments that control blood pressure, the EASI treatment appears to reverse its underlying cause, removing the need for lifelong medication. Until now, cure has required surgery to remove an entire adrenal gland.

The study, published in the New England Journal of Medicine, followed 14 people treated at eight centers across the United States. Researchers found that the EASI treatment led to sustained reversal of excess aldosterone production and partial or complete resolution of high blood pressure for up to two years after treatment ended.

Hormone levels and blood pressure remained similar to, or lower than, those recorded during their EASI treatment, suggesting that the benefits could persist long after people stop taking the drug. The findings raise the possibility that, for some people, high blood pressure could be cured rather than managed with lifelong medication.

High blood pressure, or hypertension, affects millions of people worldwide. It is estimated that between 5% and 10% of cases are caused by primary aldosteronism, a condition in which benign nodules in the adrenal glands produce too much aldosterone.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.